Patents by Inventor Alexandra Nathalie Kopic

Alexandra Nathalie Kopic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Subcutaneous administration of ADAMTS13
    Patent number: 11779635
    Abstract: This invention relates to methods of subcutaneous administration of ADAMTS13 formulations to a treat a disease or condition associated with ADAMTS13 and VWF dysfunction. Furthermore, evidence of the unexpectedly high bioavailability of ADAMTS13 formulations administered subcutaneously is provided herein.
    Type: Grant
    Filed: November 12, 2021
    Date of Patent: October 10, 2023
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Alexandra Nathalie Kopic, Werner Hoellriegl, Barbara Plaimauer, Hanspeter Rottensteiner, Eva-Maria Muchitsch
  • SUBCUTANEOUS ADMINISTRATION OF ADAMTS13
    Publication number: 20220080032
    Abstract: This invention relates to methods of subcutaneous administration of ADAMTS13 formulations to a treat a disease or condition associated with ADAMTS13 and VWF dysfunction. Furthermore, evidence of the unexpectedly high bioavailability of ADAMTS13 formulations administered subcutaneously is provided herein.
    Type: Application
    Filed: November 12, 2021
    Publication date: March 17, 2022
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Alexandra Nathalie KOPIC, Werner HOELLRIEGL, Barbara PLAIMAUER, Hanspeter ROTTENSTEINER, EVA-Maria MUCHITSCH
  • Subcutaneous administration of ADAMTS13
    Patent number: 11185575
    Abstract: This invention relates to methods of subcutaneous administration of ADAMTS13 formulations to a treat a disease or condition associated with ADAMTS13 and VWF dysfunction. Furthermore, evidence of the unexpectedly high bioavailability of ADAMTS13 formulations administered subcutaneously is provided herein.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: November 30, 2021
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Alexandra Nathalie Kopic, Werner Hollriegl, Barbara Plaimauer, Hanspeter Rottensteiner, Eva-Maria Muchitsch
  • SUBCUTANEOUS ADMINISTRATION OF ADAMTS13
    Publication number: 20200101144
    Abstract: This invention relates to methods of subcutaneous administration of ADAMTS13 formulations to a treat a disease or condition associated with ADAMTS13 and VWF dysfunction. Furthermore, evidence of the unexpectedly high bioavailability of ADAMTS13 formulations administered subcutaneously is provided herein.
    Type: Application
    Filed: September 11, 2019
    Publication date: April 2, 2020
    Applicants: BAXALTA INCORPORATED, BAXALTA GMBH
    Inventors: Alexandra Nathalie Kopic, Werner Hollriegl, Barbara Plaimauer, Hanspeter Rottensteiner, Eva-Maria Muchitsch
  • Subcutaneous administration of ADAMTS13
    Patent number: 10413600
    Abstract: This invention relates to methods of subcutaneous administration of ADAMTS13 formulations to a treat a disease or condition associated with ADAMTS13 and VWF dysfunction. Furthermore, evidence of the unexpectedly high bioavailability of ADAMTS13 formulations administered subcutaneously is provided herein.
    Type: Grant
    Filed: February 22, 2017
    Date of Patent: September 17, 2019
    Assignees: Baxalta Incorporated, Baxalta GmbH
    Inventors: Alexandra Nathalie Kopic, Werner Höllriegl, Barbara Plaimauer, Hanspeter Rottensteiner, Eva-Maria Muchitsch
  • SUBCUTANEOUS ADMINISTRATION OF ADAMTS13
    Publication number: 20170224785
    Abstract: This invention relates to methods of subcutaneous administration of ADAMTS13 formulations to a treat a disease or condition associated with ADAMTS13 and VWF dysfunction. Furthermore, evidence of the unexpectedly high bioavailability of ADAMTS13 formulations administered subcutaneously is provided herein.
    Type: Application
    Filed: February 22, 2017
    Publication date: August 10, 2017
    Applicants: BAXALTA INCORPORATED, BAXALTA GMBH
    Inventors: Alexandra Nathalie Kopic, Werner Höllriegl, Barbara Plaimauer, Hanspeter Rottensteiner, Eva-Maria Muchitsch
  • Subcutaneous administration of ADAMTS13
    Patent number: 9611467
    Abstract: This invention relates to methods of subcutaneous administration of ADAMTS13 formulations to a treat a disease or condition associated with ADAMTS13 and VWF dysfunction. Furthermore, evidence of the unexpectedly high bioavailability of ADAMTS13 formulations administered subcutaneously is provided herein.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: April 4, 2017
    Assignees: BAXALTA GMBH, BAXALTA INCORPORATED
    Inventors: Alexandra Nathalie Kopic, Werner Höllriegl, Barbara Plaimauer, Hanspeter Rottensteiner, Eva-Maria Muchitsch